144 related articles for article (PubMed ID: 22442959)
1. [Dose-dependent interferon-induction activity and pharmacokinetics of cycloferon in healthy humans].
Sukhanov DS; Romantsov MG; Smagina AN; Kovalenko AL; Lokteva OM
Eksp Klin Farmakol; 2012; 75(1):23-6. PubMed ID: 22442959
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of safety and pharmacotherapeutic efficacy of cycloferon in treatment of Astrakhan rickettsial fever].
sherysheva IuV; Galimzianov KhM; Kovalenko AL
Antibiot Khimioter; 2012; 57(1-2):26-31. PubMed ID: 22741199
[TBL] [Abstract][Full Text] [Related]
3. [Cycloferon: mechanism of action, functions and application].
Bazhanova ED
Eksp Klin Farmakol; 2012; 75(7):40-4. PubMed ID: 23025052
[TBL] [Abstract][Full Text] [Related]
4. [Individual changes of gene expression in the interferon system in human blood cells due to amixin and cycloferon].
Sokolova TM; Uryvaev LV; Tazulakhova EB; Ershov FI; Malyshenkova IK; Didkovskiĭ NA
Vopr Virusol; 2005; 50(2):32-6. PubMed ID: 15881395
[TBL] [Abstract][Full Text] [Related]
5. [Focal immunophysiotherapy in combined treatment of men with manifestations of papilloma virus infection].
Kuntsevich LD; Komov NN; Shibaeva EV; Komarova VD; Kopytova TV; Pyshkina EI; Shchelchkova NA
Urologiia; 2010; (6):58-62. PubMed ID: 21427998
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of immune response to etiotropic and pathogenetic therapy in children with chronic hepatitis C].
Vasil'eva DK; Goriacheva LG; Monakhova NE
Eksp Klin Farmakol; 2011; 74(12):33-5. PubMed ID: 22379880
[TBL] [Abstract][Full Text] [Related]
7. [Type 1 and type 2 interferon inductor (cycloferon) in therapy of children with pyelonephritis associated with herpes viruses].
Orekhova SB; Botvin'ev OK; Romantsov MG
Antibiot Khimioter; 2009; 54(5-6):48-53. PubMed ID: 20052918
[TBL] [Abstract][Full Text] [Related]
8. [Cytokinin inducing and antiviral activity of cycloferon on experimental herpetic infection].
Zmushko EI; Mitin IuA; Katsalukha VV; Sviridov LP; Nikolaev VP; Starenchenko VV
Zh Mikrobiol Epidemiol Immunobiol; 2003; (4):105-7. PubMed ID: 12966893
[TBL] [Abstract][Full Text] [Related]
9. [Cycloferon in treating duodenal ulcers in rats].
Bul'on VV; Khnychenko LK; Sapronov NS; Kuznetsova NN; Anikin VB; arinenko RIu; Kovalenko AL; Alekseeva LE
Eksp Klin Farmakol; 2001; 64(6):41-4. PubMed ID: 11871237
[TBL] [Abstract][Full Text] [Related]
10. [Cycloferon therapy of acute and chronic virus hepatitis C].
Malyĭ VP; Pen'kov DV; Chiriukina OI
Antibiot Khimioter; 2013; 58(9-10):34-40. PubMed ID: 24738241
[TBL] [Abstract][Full Text] [Related]
11. [ASSESSMENT OF INDICATORS FOR INTERFERON SYSTEM IN PATIENTS WITH COMMON FORMS OF PULMONARY TUBERCULOSIS RECEIVING COMPLEX THERAPY WITH CYCLOFERON].
Budritskii AM; Pravada NS
Eksp Klin Farmakol; 2015; 78(6):15-8. PubMed ID: 26292509
[TBL] [Abstract][Full Text] [Related]
12. [Interferon status in the treatment of neuroleptic-resistant patients with paranoid schizophrenia].
Maruta NA; Rachkauskas GS; Frolov VM; Vysochin EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):31-3. PubMed ID: 22677752
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between the endogenous interferon IFN-gamma level and risk of hepatotoxic liver damage in tuberculosis patients].
Sukhanov DS; Okovityĭ SV; Demidik SN; Ivanov AK; Romantsov MG
Eksp Klin Farmakol; 2012; 75(6):40-3. PubMed ID: 22891441
[TBL] [Abstract][Full Text] [Related]
14. [Effect of cycloferon on tonsils microflora in often ill children].
lialikov SA; Bedin PG; Ermak SIu; Ianovich RV
Eksp Klin Farmakol; 2013; 76(3):31-4. PubMed ID: 23767101
[TBL] [Abstract][Full Text] [Related]
15. [USING INTERFERON INDUCTORS IN THERAPY OF PRE-SCHOOL-AGE PATIENTS WITH REACTIVATED EPSTEIN - BARR VIRUS INFECTION.].
Khmilevakaya SA; Zaitseva IA
Eksp Klin Farmakol; 2016; 79(6):24-29. PubMed ID: 29782751
[TBL] [Abstract][Full Text] [Related]
16. Production of the Cytokines by Blood Leukocytes, Activated with Cycloferon.
Mendelenko MM; Kravchenko JN; Agadjanyan KV; Kravchenko AI
Russ J Immunol; 2001 Dec; 6(4):377-382. PubMed ID: 12687236
[TBL] [Abstract][Full Text] [Related]
17. [Immunomodulators in the "gold standard" of the chronic viral hepatitis C therapy].
Romantsov MG; Kovalenko SN; Sologub TV; Anikina OV
Antibiot Khimioter; 2008; 53(3-4):18-22. PubMed ID: 18942421
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic efficacy of various formulations of cycloferon in the treatment of infectious mononucleosis in children].
Kurmaeva DIu; Baranova IP
Antibiot Khimioter; 2011; 56(9-10):33-6. PubMed ID: 22586902
[TBL] [Abstract][Full Text] [Related]
19. [Cycloferon therapy of cytomegalovirus infection in monkeys].
Mezentseva MV; Agrba VZ; Karal-ogly DD; Agumava AA
Eksp Klin Farmakol; 2012; 75(12):37-40. PubMed ID: 23700668
[TBL] [Abstract][Full Text] [Related]
20. [Cycloferon in therapy of hyperplastic laryngitis for decrease of the number of relapses].
Grigorian SS; Romantsov MG; Demchenko EV; Kovalenko AL
Eksp Klin Farmakol; 2013; 76(7):39-42. PubMed ID: 24006616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
